David Lawrence, Chief of Business Operations at ACORDA THERAPEUTICS INC (ACOR), sold 27,109 shares at $40.11 ($1.1M) on 2014-12-18, disclosed to the SEC on 2014-12-22.
Scheduled sale ($1.1M) by Chief of Business Operations under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| ACOR | SELL | 2018-12-06 | $102K | — | Filing → |
| ACOR | SELL | 2018-06-13 | $208K | — | Filing → |
| ACOR | SELL | 2018-06-11 | $1.3M | — | Filing → |